Cellebrite DI Ltd. (NASDAQ:CLBT) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Cellebrite DI Ltd. (NASDAQ: CLBT - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the five analysts that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation and four have given a buy recommendation to the company. The average 12